Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy
- 15 July 1993
- Vol. 72 (2) , 538-548
- https://doi.org/10.1002/1097-0142(19930715)72:2<538::aid-cncr2820720234>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Monoclonal prostate-specific antigen in untreated prostate cancer. Relationship to clinical stage and gradeCancer, 1991
- Prostate-Specific Antigen and External Beam Radiation Therapy in Prostate CancerCancer, 1991
- Prostate-Specific Antigen Testing in Untreated and Treated Prostatic AdenocarcinomaMayo Clinic Proceedings, 1990
- Prostatc specific antigen as an indicator of response to radiotherapy in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. I. Untreated PatientsJournal of Urology, 1989
- Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: Long-term results of a prospective randomized studyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical ProstatectomyJournal of Urology, 1988
- The role of radiation therapy in stages A2 and B adenocarcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987